In some literatures, MUC16 mutation is associated with better prognosis and higher TMB in gastric cancer, while TTN mutation is associated with immune checkpoint blockade in solid tumors (Li et al., 2018; Yang et al., 2020). The gene discussed is MUC16; the disease is gastric cancer.